As far as I can tell AHZ is now a research and development company that just sold the rights to its premiere IP outright with a small royalty. If the company could dump the majority of its staff and focus on IP generation for a few years this would be fine. But it can’t, it still has to manufacture these patches. So the entire manufacturing staff is being kept on. No idea whAt that equates to per year, but the cash burn on this company is prodigious and always has been. And also it’s major problem.
this has still not been solved. Now is time for
another code red that actually trims the fat this time.
- Forums
- ASX - By Stock
- Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
As far as I can tell AHZ is now a research and development...
-
- There are more pages in this discussion • 150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$19.00 |
Change
0.110(0.58%) |
Mkt cap ! $365.2M |
Open | High | Low | Value | Volume |
$19.01 | $19.11 | $18.59 | $97.55K | 5.216K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 43 | $19.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.50 | 21 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43 | 19.000 |
1 | 200 | 18.800 |
1 | 1000 | 18.600 |
3 | 1475 | 18.580 |
1 | 1000 | 18.550 |
Price($) | Vol. | No. |
---|---|---|
19.500 | 21 | 1 |
20.000 | 1800 | 4 |
20.100 | 100 | 1 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online